tiprankstipranks
Trending News
More News >
Palisade Bio reports Phase 1a results for PALI-2108
PremiumThe FlyPalisade Bio reports Phase 1a results for PALI-2108
1M ago
Palisade Bio’s PALI-2108: Promising Phase 1 Results and Strategic Positioning Drive Buy Rating
Premium
Ratings
Palisade Bio’s PALI-2108: Promising Phase 1 Results and Strategic Positioning Drive Buy Rating
2M ago
Palisade Bio presents preclinical data on PALI-2108
Premium
The Fly
Palisade Bio presents preclinical data on PALI-2108
2M ago
Palisade Bio receives cash proceeds from Canada’s SR&ED tax incentive program
PremiumThe FlyPalisade Bio receives cash proceeds from Canada’s SR&ED tax incentive program
5M ago
Palisade Bio presents preclinical data of PALI-2108
Premium
The Fly
Palisade Bio presents preclinical data of PALI-2108
5M ago
Palisade Bio completes all five SAD cohorts, advanced MAD cohorts for PALI-2108
Premium
The Fly
Palisade Bio completes all five SAD cohorts, advanced MAD cohorts for PALI-2108
6M ago
Palisade Bio price target lowered to $8 from $22.50 at Maxim
PremiumThe FlyPalisade Bio price target lowered to $8 from $22.50 at Maxim
8M ago
Palisade Bio reports Q3 EPS ($2.32) vs. ($7.38) last year
Premium
The Fly
Palisade Bio reports Q3 EPS ($2.32) vs. ($7.38) last year
8M ago
Palisade Bio expects cash to fund operations through 1Q25
Premium
The Fly
Palisade Bio expects cash to fund operations through 1Q25
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100